This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: National University of Singapore. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: Innovations of Arunmozhiarasi Armugam
Introduction
Arunmozhiarasi Armugam is a notable inventor based in Singapore, recognized for his contributions to the field of biochemistry and medicinal applications. He holds a total of 3 patents, showcasing his innovative approach to addressing medical challenges.
Latest Patents
His latest patents include significant advancements in the use of phospholipase(s) for the treatment and prevention of ischemia. One of his inventions focuses on secretory phospholipase A derived from snake venom, which has potential applications in developing medicaments. Another patent details a phospholipase A inhibitor protein, known as 'Phospholipase Inhibitor from Python' (PIP), which exhibits strong lethal toxin neutralizing activity and anti-inflammatory properties. This invention is crucial for treating conditions such as snakebites, insect stings, and various inflammatory diseases. Additionally, he has disclosed phospholipase A inhibitory polypeptides that can be utilized in diagnosing and treating PLA-related human inflammatory diseases.
Career Highlights
Arunmozhiarasi Armugam is affiliated with the National University of Singapore, where he continues to contribute to research and innovation in his field. His work has garnered attention for its potential impact on medical treatments and therapeutic methods.
Collaborations
He collaborates with esteemed colleagues, including Kandiah Jeyaseelan and Ponnampalam Gopalakrishnakone, further enhancing the scope and depth of his research endeavors.
Conclusion
Arunmozhiarasi Armugam's innovative work in the field of biochemistry and his patents reflect his commitment to advancing medical science. His contributions are paving the way for new treatments and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile